Literature DB >> 8558064

The Duffy antigen receptor for chemokines: structural analysis and expression in the brain.

R Horuk1, A Martin, J Hesselgesser, T Hadley, Z H Lu, Z X Wang, S C Peiper.   

Abstract

The Duffy antigen receptor for chemokines (DARC) is expressed in human erythrocytes and on endothelial cells lining postcapillary venules in kidney and spleen. DARC is a promiscuous chemokine receptor and a binding protein for the malarial parasite Plasmodium vivax. The expression of DARC by subsets of endothelial cells and neurons in discrete anatomic sites in the brain suggests that this enigmatic receptor may have multiple roles in normal and pathological physiology. Conservation of this promiscuous chemokine binding function is evident from the similarity in nucleotide sequence of DARC homologues from multiple species, as well as the high-affinity binding of human chemokines to murine and avian erythrocytes. Analysis of the functional domains of DARC using chimeric receptors and and monoclonal antibodies to multiple extracellular domains localized chemokine binding to structures in the amino terminal extracellular domain (E1). Scatchard analysis demonstrated that a chimeric DARC receptor, composed of the E1 domain of DARC and the predicted hydrophobic helices and loops of interleukin-8RB (IL-8RB), bound IL-8, and MGSA with KD values almost identical to the wild type receptors and bound a repertoire of C-X-C and C-C chemokines characteristic of DARC. Although numerous reports have demonstrated that chemokines such as IL-8 are expressed in the brain, presumably by glial cells, little insight into the nature of their role in normal or pathological physiology in the nervous system has developed because the target cells that express the corresponding receptors have not yet been identified. Northern blotting experiments suggest that mRNA encoding DARC are expressed in the central nervous system, however, interpretation of this is unclear because of the ubiquitous expression of DARC lining postcapillary venules. This study provides direct evidence to localize expression of DARC in the central nervous system. Immunohistochemical examination of human archival sections of the brain with monoclonal antibodies specific for DARC localize expression of DARC to cell bodies and processes of Purkinjie cells in the cerebellum. The immunohistochemical findings were supported by analysis of chemokine binding and radioligand crosslinking with membranes made from various brain fractions. The hierarchical expression of DARC in neurons in the cerebellum suggest that chemokines may play an important role in the modulation of neuronal activity by glial cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558064     DOI: 10.1002/jlb.59.1.29

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  26 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

Review 2.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

3.  CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons.

Authors:  E Lavi; J M Strizki; A M Ulrich; W Zhang; L Fu; Q Wang; M O'Connor; J A Hoxie; F González-Scarano
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

4.  Shedding light on DARC: the role of the Duffy antigen/receptor for chemokines in inflammation, infection and malignancy.

Authors:  K Horne; Ian J Woolley
Journal:  Inflamm Res       Date:  2009-03-17       Impact factor: 4.575

5.  Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits.

Authors:  R A Dumont; B D Car; N N Voitenok; U Junker; B Moser; O Zak; T O'Reilly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model.

Authors:  D A Barnes; J Tse; M Kaufhold; M Owen; J Hesselgesser; R Strieter; R Horuk; H D Perez
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

7.  Regulation of motor function and behavior by atypical chemokine receptor 1.

Authors:  Erich H Schneider; Stephen C Fowler; Michail S Lionakis; Muthulekha Swamydas; Gibran Holmes; Vivian Diaz; Jeeva Munasinghe; Stephen C Peiper; Ji-Liang Gao; Philip M Murphy
Journal:  Behav Genet       Date:  2014-07-06       Impact factor: 2.805

Review 8.  Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.

Authors:  R Cotter; C Williams; L Ryan; David Erichsen; A Lopez; H Peng; J Zheng
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

9.  The neural cell adhesion molecule is a receptor for rabies virus.

Authors:  M I Thoulouze; M Lafage; M Schachner; U Hartmann; H Cremer; M Lafon
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines.

Authors:  Christophe Tournamille; Antoine Blancher; Caroline Le Van Kim; Pierre Gane; Pol André Apoil; Wilson Nakamoto; Jean Pierre Cartron; Yves Colin
Journal:  Immunogenetics       Date:  2004-01-08       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.